EMAT enters the second week of July nursing a bruising month — down 13% to $5.77 — while its borrow market tells a quietly interesting counter-story of easing pressure after weeks of extreme tightness.
The standout angle for Evolution Metals & Technologies right now is the shift in borrow availability. For most of June, the lending pool was effectively locked up: availability dropped as low as 18% on June 15, and the stock spent nearly two consecutive weeks with utilization pegged at 100% — meaning every share in the lending pool was lent out simultaneously. That extreme tightness has since unwound. Availability has climbed back to roughly 81% this week, up 30% from a week ago, suggesting lenders have added supply or shorts have trimmed. The cost to borrow has edged down alongside — running at about 29.5%, off from a recent high near 34% in mid-June, though it remains firmly elevated and classifies as a high-cost borrow. Short shares outstanding are also drifting lower, falling around 4% from their mid-June peak of ~462,000 to roughly 422,000 now, though the monthly comparison still shows a modest 7% build from late May levels.
The ORTEX short score adds a quiet corroboration to the easing narrative. At 62.9 as of July 7, the score has been sliding gradually from 63.8 a fortnight ago — not a dramatic swing, but a consistent directional step-down that aligns with the marginal reduction in short positioning and the loosening borrow market. The score remains elevated in absolute terms, reflecting an ongoing bearish lean, but momentum is no longer building on the short side.
What's driving the price weakness is a more open question. The stock is down 13% over both the past week and the past month — a near-identical decline that implies the damage arrived in a single, sharp move rather than a steady grind. Earnings history for EMAT is volatile: the last four releases produced day-one swings of -14%, +19%, +22%, and -16%, with no reliable directional pattern. The next event is scheduled for August 20. Ownership is heavily concentrated — the two largest holders, William Wilcox and Andrew Knaggs, collectively control roughly 80% of shares outstanding, which compresses the tradeable float and amplifies any borrow-market signals on the remaining shares. Institutional coverage beyond the founders is thin, with Robertson Stephens the only recognizable institutional name and even their position amounting to under 0.5% of shares outstanding. There is no recent analyst coverage to reference; the prior note from June cited rare-earth supply contract news as a positive catalyst, but the stock has since given back those gains and more.
Correlating peers offer limited comfort. RDS on the TSXV gained more than 20% on the week while EMAT fell 13% — a notable divergence among names with 42% historical correlation. Most other correlated names were flat to modestly higher, making EMAT's slide look more idiosyncratic than sector-driven.
The setup heading into August 20 earnings is therefore less about sector macro and more about whether the loosening borrow market reflects genuine short-covering — or simply a lender adding supply into a falling price that leaves positioning largely intact.
See the live data behind this article on ORTEX.
Open EMAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
